Bridgeway Capital Management LLC Invests $1.16 Million in Phibro Animal Health Co. (NASDAQ:PAHC)

Bridgeway Capital Management LLC purchased a new position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 55,000 shares of the company's stock, valued at approximately $1,155,000. Bridgeway Capital Management LLC owned approximately 0.14% of Phibro Animal Health at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Barclays PLC raised its position in shares of Phibro Animal Health by 25.7% in the third quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after buying an additional 29,271 shares in the last quarter. SG Americas Securities LLC increased its stake in Phibro Animal Health by 7.4% in the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after acquiring an additional 906 shares during the last quarter. Inspire Investing LLC bought a new stake in shares of Phibro Animal Health during the 4th quarter valued at about $791,000. Smith Group Asset Management LLC purchased a new position in shares of Phibro Animal Health during the fourth quarter worth about $541,000. Finally, New York State Teachers Retirement System increased its position in shares of Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock worth $114,000 after purchasing an additional 775 shares during the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

NASDAQ:PAHC traded down $1.24 during midday trading on Wednesday, hitting $23.36. The company had a trading volume of 291,513 shares, compared to its average volume of 195,539. The company has a market capitalization of $946.15 million, a PE ratio of 48.67, a P/E/G ratio of 0.45 and a beta of 0.62. Phibro Animal Health Co. has a 52-week low of $16.16 and a 52-week high of $26.55. The stock's fifty day moving average price is $20.04 and its 200-day moving average price is $21.86. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. The company had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. As a group, research analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.05%. Phibro Animal Health's dividend payout ratio (DPR) is currently 61.54%.

Analyst Upgrades and Downgrades

PAHC has been the subject of several research analyst reports. Barclays lifted their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. StockNews.com raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $20.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.